DMAA
Drugs Made In America Acquisition Corp.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
—
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
—
Drugs Made In America Acquisition Corp.
Expected move
InputsNext report
Last report
—
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
—
No other changes.
No other changes.
No trades yet today.
No trades yet today.
Same SIC code · 6
Same SEC industry code: Innventure, Inc., Artius II Acquisition Inc., Armada Acquisition Corp. III and 3 more; no measured co-movers for Drugs Made In America Acquisition Corp..
Same SIC code · 6
Same SEC industry code: Innventure, Inc., Artius II Acquisition Inc., Armada Acquisition Corp. III and 3 more; no measured co-movers for Drugs Made In America Acquisition Corp..
Annual filing, covered
10-K parsed · Apr 15 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Apr 15 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
Drugs Made In America Acquisition Corp.
10.89
Drugs Made In America Acquisition Corp. is a blank check company newly incorporated in the Cayman Islands as an exempted company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. To date, our efforts have been limited to organizational activities as well as activities related to this offering. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. While we may pursue a business combination target in any business, industry or geographical location, we intend to focus our search for businesses in the pharmaceutical industry. Our executive offices are located at 1 East Broward Boulevard, Suite 700, Fort Lauderdale, FL 33301 and our telephone number is (954) 870-3099.
Drugs Made In America Acquisition Corp. is a blank check company newly incorporated in the Cayman Islands as an exempted company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. To date, our efforts have been limited to organizational activities as well as activities related to this offering. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. While we may pursue a business combination target in any business, industry or geographical location, we intend to focus our search for businesses in the pharmaceutical industry. Our executive offices are located at 1 East Broward Boulevard, Suite 700, Fort Lauderdale, FL 33301 and our telephone number is (954) 870-3099.
Tall tick = annual report · Source: EDGAR
Expected move
No implied move.
−18.19%
shares held · 10 largest managers
| Manager | Value | % base | |
|---|---|---|---|
| Mizuho Securities USA | $42.8M | 28.90% | +103.48% |
| Karpus | $26.7M | 18.02% | −0.90% |
| Polar Asset Management Partners | $12.2M | 8.24% | −28.38% |
| Glazer Capital | $10.6M | 7.19% | −40.43% |
| Wolverine | $8.9M | 5.98% | −46.44% |
| Manager | Value | % base | |
|---|---|---|---|
| Mizuho Securities USA | $42.8M | 28.90% | +103.48% |
| Karpus | $26.7M | 18.02% | −0.90% |
| Polar Asset Management Partners | $12.2M | 8.24% | −28.38% |
| Glazer Capital | $10.6M | 7.19% | −40.43% |
| Wolverine | $8.9M | 5.98% | −46.44% |